This inventor holds 6 USPTO granted patents and 8 published patent applications and 6 EPO patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2013-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2024
Title: Zongxing Qiu: Innovator in Autoimmune Disease Treatment
Introduction
Zongxing Qiu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of autoimmune diseases. With a total of 6 patents to his name, Qiu's work has the potential to impact many lives.
Latest Patents
Among his latest patents, Qiu has developed piperazine compounds aimed at treating autoimmune diseases. These compounds are described by a specific formula, including their pharmaceutically acceptable salts, enantiomers, or diastereomers. Additionally, he has created cyclic amidine compounds that serve as antagonists of TLR7, TLR8, and TLR9, which are crucial in the treatment of autoimmune and auto-inflammatory diseases.
Career Highlights
Zongxing Qiu has worked with notable companies such as Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Qiu has collaborated with esteemed colleagues, including Xianfeng Lin and Guozhi Tang. These partnerships have further enhanced his research and development efforts in the pharmaceutical industry.
Conclusion
Zongxing Qiu is a dedicated inventor whose work in autoimmune disease treatment showcases his innovative spirit and commitment to improving healthcare. His contributions through patents and collaborations highlight the importance of research in addressing complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile